JP2023156196A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023156196A5 JP2023156196A5 JP2022065933A JP2022065933A JP2023156196A5 JP 2023156196 A5 JP2023156196 A5 JP 2023156196A5 JP 2022065933 A JP2022065933 A JP 2022065933A JP 2022065933 A JP2022065933 A JP 2022065933A JP 2023156196 A5 JP2023156196 A5 JP 2023156196A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- sequence represented
- cdr1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 42
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 241001678559 COVID-19 virus Species 0.000 claims 4
- 108010003723 Single-Domain Antibodies Proteins 0.000 claims 4
- 208000025721 COVID-19 Diseases 0.000 claims 1
- 101710141454 Nucleoprotein Proteins 0.000 claims 1
- 208000037847 SARS-CoV-2-infection Diseases 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022065933A JP2023156196A (ja) | 2022-04-12 | 2022-04-12 | 抗ＳＡＲＳ－ＣｏＶ－２抗体 |
| PCT/JP2023/014930 WO2023199955A1 (ja) | 2022-04-12 | 2023-04-12 | 抗ＳＡＲＳ－ＣｏＶ－２抗体 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022065933A JP2023156196A (ja) | 2022-04-12 | 2022-04-12 | 抗ＳＡＲＳ－ＣｏＶ－２抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023156196A JP2023156196A (ja) | 2023-10-24 |
| JP2023156196A5 true JP2023156196A5 (https=) | 2025-04-02 |
Family
ID=88329816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022065933A Pending JP2023156196A (ja) | 2022-04-12 | 2022-04-12 | 抗ＳＡＲＳ－ＣｏＶ－２抗体 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2023156196A (https=) |
| WO (1) | WO2023199955A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111153991A (zh) * | 2020-02-26 | 2020-05-15 | 北京博奥森生物技术有限公司 | 一种人SARS-CoV-2单克隆抗体及其制备方法和应用 |
| CN112028993B (zh) * | 2020-10-15 | 2022-09-06 | 武汉华美生物工程有限公司 | 一种抗sars-cov-2病毒n蛋白的纳米抗体及其制备方法和应用 |
| WO2022181550A1 (ja) * | 2021-02-25 | 2022-09-01 | 花王株式会社 | 抗ＳＡＲＳ－ＣｏＶ－２抗体 |
-
2022
- 2022-04-12 JP JP2022065933A patent/JP2023156196A/ja active Pending
-
2023
- 2023-04-12 WO PCT/JP2023/014930 patent/WO2023199955A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2021222316A2 (en) | Variant nucleic acid libraries for coronavirus | |
| JP2021105034A5 (https=) | ||
| WO2023023190A2 (en) | Single domain antibodies for sars-cov-2 | |
| JP2013500940A5 (https=) | ||
| Akter et al. | Broad-spectrum noncompetitive immunocomplex immunoassay for cyanobacterial peptide hepatotoxins (microcystins and nodularins) | |
| JP2020500508A5 (https=) | ||
| JP2015531768A5 (https=) | ||
| WO2023076420A2 (en) | Multispecific sars-cov-2 antibodies and methods of use | |
| JP2015527368A5 (https=) | ||
| JP2016516400A5 (https=) | ||
| CN117720650B (zh) | 抗人呼吸道合胞病毒抗体及其应用 | |
| JPWO2021048725A5 (https=) | ||
| JP2021520492A5 (https=) | ||
| JP2015527365A5 (https=) | ||
| JP2018527895A5 (https=) | ||
| JP2019504014A5 (https=) | ||
| JP2019504013A5 (https=) | ||
| JP2020189843A5 (https=) | ||
| JP2021515597A5 (https=) | ||
| Ch’ng et al. | Phage display-derived antibodies: Application of recombinant antibodies for diagnostics | |
| IL186509A (en) | Reagents that bind ccx-ckr2 | |
| Trilling et al. | A broad set of different llama antibodies specific for a 16 kDa heat shock protein of Mycobacterium tuberculosis | |
| JP2023156196A5 (https=) | ||
| JP2023156197A5 (https=) | ||
| JP2024143793A5 (https=) |